Login / Signup

Serological Response and Relationship with Gender-Sensitive Variables among Healthcare Workers after SARS-CoV-2 Vaccination.

Roberto CangemiManuela Di FrancoAntonio AngeloniAlessandra ZicariVincenzo CardinaleMarcella VisentiniGuido AntonelliAnna NapoliEmanuela AnastasiGiulio Francesco RomitiFabrizio d'AlbaDomenico AlvaroAntonella PolimeniStefania Basilinull Sapienzavax Collaborators
Published in: Journal of personalized medicine (2022)
Vaccine-induced immunity is a key strategy in the long-term control of the COVID-19 pandemic. The aim of our study was to explore the relationship between mRNA vaccine-induced antibodies and gender-sensitive variables among healthcare workers. Two thousand-sixty-five volunteers who received the BNT162b2 vaccine were enrolled in the study and followed up. Demographic, clinical, and social variables (educational level, marital status, occupation, childcare) were evaluated through a self-administered questionnaire. Anti-Spike (S) IgG were measured at 1 month (T1) and at 5 months (T2) after the second vaccine dose. At T1, median anti-S IgG values were 693 [394->800] AU/mL (1 AU = 2.6 BAU). Values > 800 AU/mL (2080 BAU/mL) were directly associated with a previous COVID-19 ( p < 0.001) infection and inversely with age ( p < 0.001), smoking habit ( p < 0.001), and autoimmune diseases ( p < 0.001). At T2, a significant decreasing in anti-S IgG values was observed (187 [81-262] AU/mL), with a median decrease of 72 [60-82]%. On multivariate data analysis, a reduction of more than 82% was directly associated with male sex ( p < 0.021), age ( p < 0.001), smoking ( p = 0.038), hypertension ( p = 0.042), and, inversely, with previous COVID-19 infection ( p < 0.001) and being "cohabiting" ( p = 0.005). Our findings suggest that demographic, clinical, and social variables play a role in anti-S IgG values decreasing in long-term follow up and should be considered to find personalized vaccine schedules.
Keyphrases